Phibro Animal Health Corporation is a diversified animal health and mineral nutrition company. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets animal health products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products include antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent diseases; anticoccidials to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics for treating infestations of parasitic intestinal worms; anti-bloat treatment products used in cattle to control bloat in animals grazing on legume, or wheat-pasture; and medicated feed additives and other related products. The companys animal health products also comprise nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily in the poultry and swine industries. In addition, it manufactures and markets approximately formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds.
Closing share price